| Ytd | -61.38% | |
| 1y | -65.22% |
| Open | 1.11 | Prev Close | 1.09 | Low | 1.09 | High | 1.20 | Mkt Cap | 56.18M |
| Vol | 721.10K | Avg Vol | 245.96K | EPS | -1.11 | P/E | N/A | Forward P/E | -1.02 |
| Beta | 1.08 | Short Ratio | 0.38 | Inst. Own | 57.65% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-06 | 50-d Avg | 1.71 | 200-d Avg | 2.61 | 1yr Est | 8.00 |
LEXINGTON, Mass., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (th
Rapid Micro Biosystems (RPID) has become technically an oversold stock now, which implies exhaustion
The heavy selling pressure might have exhausted for Rapid Micro Biosystems (RPID) as it is technical
Many Bright Ideas Technologies (OTCMKTS:MBGNF - Get Free Report) and Rapid Micro Biosystems (NASDAQ:
Rapid Micro Biosystems (RPID) might move higher on growing optimism about its earnings prospects, wh
Rapid Micro Biosystems, Inc. (RPID) Q2 2026 Earnings Call Transcript
Rapid Micro Biosystems NASDAQ: RPID reported second-quarter revenue of $8.1 million, up 11% from $7.
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.27 per share versus the Zac
Rapid Micro Biosystems (NASDAQ:RPID) affirms FY2026 sales outlook from $37.000 million-$41.000 milli
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.27) per share which missed the
Reports second quarter 2026 total revenue of $8.1 million , representing 11% growth compared to the
LEXINGTON, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the
LEXINGTON, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the
Gainers EUDA Health Holdings (NASDAQ:EUDA) shares rose 22.3% to $15.2 during Friday's regular s
LEXINGTON, Mass., June 10, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the
Keybanc analyst Paul Knight maintains Rapid Micro Biosystems (NASDAQ:RPID) with a Overweight and
Lake Street analyst Thomas Flaten maintains Rapid Micro Biosystems (NASDAQ:RPID) with a Buy and l
LEXINGTON, Mass. , May 18, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. ("Rapid Micro Biosy
Rapid Micro Biosystems NASDAQ: RPID reported first-quarter 2026 revenue growth and reaffirmed its fu
Rapid Micro Biosystems, Inc. (RPID) Q1 2026 Earnings Call Transcript
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.31 per share versus the Zac
Rapid Micro Biosystems (NASDAQ:RPID) affirms FY2026 sales outlook from $37.000 million-$41.000 milli
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.31) per share which missed the
LEXINGTON, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the
LEXINGTON, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the
Rapid Micro Biosystems (RPID) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimis
Rapid Micro Biosystems (NASDAQ:RPID) sees FY2026 sales of $37.000 million-$41.000 million vs $40.125
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.28) per share which missed the
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the "Company"), an innovative life sciences tec
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.26) per share which missed the
Trinity Capital Inc. (NASDAQ:TRIN) (the "Company"), a leading alternative asset manager, tod
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.27) per share which missed the
Lake Street analyst Thomas Flaten initiates coverage on Rapid Micro Biosystems (NASDAQ:RPID) with
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.26) per share which beat the a
Rapid Micro Biosystems (NASDAQ:RPID) sees FY2025 sales of $32.000 million vs $32.90 million analyst